144 related articles for article (PubMed ID: 22157559)
1. Gene expression analysis and immunohistochemistry in evaluation of cancer of unknown primary: time for a patient-centered approach.
Handorf CR
J Natl Compr Canc Netw; 2011 Dec; 9(12):1415-20. PubMed ID: 22157559
[TBL] [Abstract][Full Text] [Related]
2. Cancer of unknown primary site: evolving understanding and management of patients.
Greco FA
Clin Adv Hematol Oncol; 2012 Aug; 10(8):518-24. PubMed ID: 23073050
[TBL] [Abstract][Full Text] [Related]
3. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
4. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
6. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
Greco FA
Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
[TBL] [Abstract][Full Text] [Related]
8. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.
Tothill RW; Li J; Mileshkin L; Doig K; Siganakis T; Cowin P; Fellowes A; Semple T; Fox S; Byron K; Kowalczyk A; Thomas D; Schofield P; Bowtell DD
J Pathol; 2013 Dec; 231(4):413-23. PubMed ID: 24037760
[TBL] [Abstract][Full Text] [Related]
9. Cancer of unknown primary site: improved patient management with molecular and immunohistochemical diagnosis.
Greco FA
Am Soc Clin Oncol Educ Book; 2013; ():175-81. PubMed ID: 23714493
[TBL] [Abstract][Full Text] [Related]
10. Unknown primary tumors.
Natoli C; Ramazzotti V; Nappi O; Giacomini P; Palmeri S; Salvatore M; Landriscina M; Zilli M; Natali PG; Tinari N; Iacobelli S
Biochim Biophys Acta; 2011 Aug; 1816(1):13-24. PubMed ID: 21371531
[TBL] [Abstract][Full Text] [Related]
11. Occult primary, version 3.2014.
Ettinger DS; Handorf CR; Agulnik M; Bowles DW; Cates JM; Cristea M; Dotan E; Eaton KD; Fidias PM; Gierada D; Gilcrease GW; Godby K; Iyer R; Lenzi R; Phay J; Rashid A; Saltz L; Schwab RB; Shulman LN; Smerage JB; Stevenson MM; Varadhachary GR; Zager JS; Zhen WK; Bergman MA; Freedman-Cass DA;
J Natl Compr Canc Netw; 2014 Jul; 12(7):969-74. PubMed ID: 24994917
[TBL] [Abstract][Full Text] [Related]
12. Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
Booth CM
Clin Cancer Res; 2010 Dec; 16(24):5963-71. PubMed ID: 21169249
[TBL] [Abstract][Full Text] [Related]
13. Genomic Profiling of Cancers of Unknown Primary Site--Reply.
Ross JS; Miller VA; Stephens PJ
JAMA Oncol; 2015 Jul; 1(4):542-3. PubMed ID: 26181269
[No Abstract] [Full Text] [Related]
14. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
Cobain EF; Chinnaiyan AM; Kurzrock R; Baker LH
JAMA Oncol; 2015 Jul; 1(4):542. PubMed ID: 26181268
[No Abstract] [Full Text] [Related]
15. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
Varghese AM; Saltz LB
JAMA Oncol; 2015 Jul; 1(4):541-2. PubMed ID: 26181267
[No Abstract] [Full Text] [Related]
16. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
Whang YE; Hayes DN
JAMA Oncol; 2015 Jul; 1(4):541. PubMed ID: 26181266
[No Abstract] [Full Text] [Related]
17. Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.
Hainsworth JD; Greco FA
Am Soc Clin Oncol Educ Book; 2018 May; 38():20-25. PubMed ID: 30231392
[No Abstract] [Full Text] [Related]
18. Cancer from an unknown primary site.
Dowell JE
Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902
[TBL] [Abstract][Full Text] [Related]
20. A care model for the future: the oncology medical home.
Eagle D; Sprandio J
Oncology (Williston Park); 2011 Jun; 25(7):571, 575-6. PubMed ID: 21888254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
